Literature DB >> 15196244

Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset.

B C Holm1, J C Lorentzen, A Bucht.   

Abstract

A single intradermal injection of the adjuvant-oil squalene induces T cell mediated arthritis in DA rats. The chain of events leading from nonspecific provocation of the immune system to arthritis is largely unknown. Previous studies have demonstrated that lymph node (LN) cells are of pathogenic importance, i.e. cells from LNs draining the injection site can transfer arthritis to naïve DA rats. Recently we have demonstrated cellular uptake of adjuvant oil in draining lymph nodes but also that nondraining LNs become hyperplastic and harbour arthritogenic cells. Here, we aimed to determine from which time-point prior to arthritis onset arthritogenic cells appear in draining inguinal and nondraining axillary/brachial LNs, respectively. We demonstrated that the ability to transfer arthritis was strongly dependent on the time-point after adjuvant-injection with clear-cut differences between draining and nondraining LN cells. Cells harvested at day 5 postinjection (p.i) were not able to transfer arthritis, while at day 8 p.i, a first wave of arthritogenic cells appeared in draining LNs. The ability to transfer arthritis was associated with a pro-inflammatory cytokine profile as indicated by the IL-1beta and IFNgamma expression in cells from draining LNs. Subsequently, at day 11 p.i., just before arthritis onset, arthritogenic cells appeared also in nondraining LNs. These results shed new light on the induction of arthritic diseases, implicating a two step mechanism for the development of pathogenic cells. Firstly, a pro-inflammatory burst in responding lymphoid organs leading to a local pool of arthritogenic cells and, secondly, a transmission of arthritogenecity to other LNs and precipitation of disease in peripheral joints.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196244      PMCID: PMC1809090          DOI: 10.1111/j.1365-2249.2004.02498.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes.

Authors:  B C Holm; L Svelander; A Bucht; J C Lorentzen
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Responses of the rat immune system to arthritogenic adjuvant oil.

Authors:  L Svelander; B C Holm; A Buchtt; J C Lorentzen
Journal:  Scand J Immunol       Date:  2001-12       Impact factor: 3.487

3.  Rats made congenic for Oia3 on chromosome 10 become susceptible to squalene-induced arthritis.

Authors:  B C Holm; H W Xu; L Jacobsson; A Larsson; H Luthman; J C Lorentzen
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue.

Authors:  U Wendling; L Paul; R van der Zee; B Prakken; M Singh; W van Eden
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

6.  CD8+ cells suppress oil-induced arthritis.

Authors:  A M Jansson; J C Lorentzen; A Bucht
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 7.  Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis.

Authors:  R Holmdahl; J C Lorentzen; S Lu; P Olofsson; L Wester; J Holmberg; U Pettersson
Journal:  Immunol Rev       Date:  2001-12       Impact factor: 12.988

Review 8.  Macrophages in rheumatoid arthritis.

Authors:  R W Kinne; R Bräuer; B Stuhlmüller; E Palombo-Kinne; G R Burmester
Journal:  Arthritis Res       Date:  2000-04-12

Review 9.  Genes and environment in arthritis: can RA be prevented?

Authors:  Lars Klareskog; Johnny Lorentzen; Leonid Padyukov; Lars Alfredsson
Journal:  Arthritis Res       Date:  2002-05-09

10.  Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement.

Authors:  S Kleinau; H Erlandsson; R Holmdahl; L Klareskog
Journal:  J Autoimmun       Date:  1991-12       Impact factor: 7.094

View more
  6 in total

Review 1.  Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.

Authors:  Margaret F Bassendine; Simon H Bridge
Journal:  Eur J Rheumatol       Date:  2019-12-16

2.  Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis.

Authors:  S M Nanjundaiah; J P Stains; K D Moudgil
Journal:  Int J Immunopathol Pharmacol       Date:  2013 Jan-Mar       Impact factor: 3.219

3.  Adjuvants- and vaccines-induced autoimmunity: animal models.

Authors:  Jiram Torres Ruiz; Luis Luján; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

4.  Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis.

Authors:  Cheri L Lubahn; Dianne Lorton; Jill A Schaller; Sarah J Sweeney; Denise L Bellinger
Journal:  Front Immunol       Date:  2014-08-11       Impact factor: 7.561

5.  Phytol-derived novel isoprenoid immunostimulants.

Authors:  Roshni Roy Chowdhury; Swapan K Ghosh
Journal:  Front Immunol       Date:  2012-03-22       Impact factor: 7.561

Review 6.  Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Authors:  Nikolai Petrovsky
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.